Showing 821-830 of 1097 results for "".
- Few Patients Undergo Recommended MRI Screening After Silicone Implant Breast Surgeryhttps://modernaesthetics.com/news/few-patients-undergo-recommended-mri-screening-after-silicone-implant-breast-surgery/2473272/Only six percent of women with silicone breast implants followed the previous FDA recommendation for regular magnetic resonance imaging (MRI) screening, suggests a study in Plastic and Reconstructive Surgery®, the o
- The Skinny on TikTok Face and Other Social Media Beauty Hackshttps://modernaesthetics.com/news/tiktok-face-and-other-social-media-beauty-hacks/2473267/“TikTok Face” is the media-given name for all sorts of poses (think shielding your face like you're evading the paparazzi) and hacks such as taping to reduce wrinkles or contouring with sunscreen so you look better in your photos and in person. And it’s c
- FDA Nod for Sientra’s Low Plus Profile Projection Breast Implanthttps://modernaesthetics.com/news/fda-nod-for-sientras-low-plus-profile-projection-breast-implant-1/2473263/The U.S. Food and Drug Administration (FDA) approved Sientra’s Low Plus Profile Projection Breast Implant for breast augmentation in women at least 22 years old, and for women of all ages undergoing breast reconstruction. This product will be commercially available for board-certi
- Cynosure Launches Innovative Tempsure eyeEnvi Handpiece with Improved Function and Greater Comforthttps://modernaesthetics.com/news/cynosure-launches-innovative-tempsure-eyeenvi-handpiece-with-improved-function-and-greater-comfort/2473262/Cynosure's new Tempsure eyeEnvi handpiece features innovative ergonomic pencil grip design and lighter piston tension required to activate the treatment, making it more comfortable for both patient and provider, heating thinner tissue more effectively and comfortably while minimizin
- Galderma to Participate in New York's PrideFest Sundayhttps://modernaesthetics.com/news/galderma-to-participate-in-new-yorks-pridefest-sunday/2473261/Galderma is participating in New York City's official LGBTQIA+ Pride (NYC Pride) event. This month marks the official launch of Restylane's "XpresYourself" communications campaign, which gives a nod to Restylane's XpresHAn Technology™, a u
- Plastic Surgery Residents Report Barriers to Affordable Childcarehttps://modernaesthetics.com/news/plastic-surgery-residents-report-barriers-to-affordable-childcare/2473246/Plastic surgery residents face persistent barriers accessing affordable childcare, with high costs and a major impact on surgical training—with most of the burden falling on women residents, finds a study in the June issue of Plastic and Reconstructive Surgery. The researchers sen
- Merz Aesthetics Partners with North Carolina Courage, Reigning NWSL Challenge Cup Championshttps://modernaesthetics.com/news/merz-aesthetics-partners-with-north-carolina-courage-reigning-nwsl-challenge-cup-champions/2473240/In a new partnership with the North Carolina Courage, reigning NWSL Challenge Cup Champions and two-time champions of the National Women’s Soccer League (NWSL), Merz Aesthetics aims to promote confidence, character, and sportsmanship. The partnership, kicking off Sunday, includes
- CoolSculpting's New DTC Campaign is Brand's First to Feature Real Experiences with Treatmenthttps://modernaesthetics.com/news/coolsculptings-new-dtc-campaign-is-brands-first-to-feature-real-experiences-with-treatment/2473238/The newest direct-to-consumer campaign from CoolSculpting® launches this month and marks the first time the brand is featuring the real experiences of real people who have been treated with CoolSculpting® and CoolTone®. “CoolSculpting® Takes You Further&rdquo
- New Ophthalmologist-Created Eye Skincare Line Launcheshttps://modernaesthetics.com/news/new-ophthalmologist-created-eye-skincare-line-launches/2473236/Now available for pre-order, Daily Practice, the new eye care line by Ashley Brissette, MD, has launched with a hero product—Eye Revive. Having worked as an ophthalmologist for six years, New York City-based Dr. Brissette says she recognized a grow
- Revance News: FDA Accepts BLA Resubmission for DaxibotulinumtoxinAhttps://modernaesthetics.com/news/revance-news-fda-accepts-bla-resubmission-for-daxibotulinumtoxina/2473223/The U.S. Food and Drug Administration (FDA) accepted Revance’s Biologics License Application (BLA) resubmission for DaxibotulinumtoxinA for Injection for the treatment of moderate to severe glabellar lines. The FDA designated the BLA as a Class 2 resubmission, which has a six-mont